Tarsons Products quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	110	91.4	+20.7%
EBITDA	26.0	24.7	+5.2%
EBITDA margin	23.6%	27.0%	−3.5 pts
Profit before tax	−1.3	3.0	—
Net profit	−1.4	1.8	—
EPS	−₹0.27	₹0.34	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q4 FY22Mar 2022	Earlier quartersAlpha Plus

Expenses
	110	121	108	102	91.4	113	95.7	99.2	84.8	106	61.8	84.9	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	6.0	6.6	8.4	5.8	3.3	3.8	0.8	8.4	2.9	3.4	3.2	2.6
	116	128	116	108	94.7	116	96.5	108	87.7	109	65.0	87.5
	22.2	21.9	17.9	17.3	15.8	21.9	19.6	18.3	20.3	16.3	15.3	20.0
	12.6	14.5	14.3	10.4	10.6	11.8	11.2	13.0	15.1	8.7	2.0	2.9
	3.9	4.8	3.0	5.5	2.9	4.2	0.5	1.4	−7.7	8.2	−0.7	−3.9
	21.2	20.4	19.5	17.8	17.9	16.8	16.4	16.1	16.1	15.6	9.8	8.6
	6.3	6.3	6.0	5.2	5.1	5.2	5.0	4.8	4.3	4.3	2.5	0.5
	27.0	29.1	25.0	22.5	19.9	20.0	17.4	14.0	11.0	12.3	10.1	7.2
	24.3	25.1	21.7	23.8	19.5	21.0	18.4	25.2	22.3	26.7	12.5	13.0
	118	122	107	103	91.7	101	88.5	92.8	81.4	92.1	51.5	48.3
	26.0	34.3	31.5	27.4	24.7	37.0	29.6	25.3	18.8	30.2	22.9	44.3
	−1.0	5.2	6.5	5.0	4.8	17.0	12.2	11.3	7.7	17.9	12.8	37.1
Profit
	−1.3	5.5	8.9	5.6	3.0	15.6	8.0	14.9	6.3	17.0	13.6	39.2
	0.0	0.2	−1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−1.3	5.8	7.5	5.6	3.0	15.6	8.0	14.9	6.3	17.0	13.6	39.2
	0.2	0.0	2.5	2.3	1.3	6.3	2.5	3.6	2.5	8.2	3.3	9.1
	−0.1	1.6	−0.0	−0.0	−0.1	−0.9	0.3	1.0	−0.2	−1.4	0.4	0.6
	0.1	1.6	2.5	2.3	1.2	5.4	2.8	4.6	2.3	6.7	3.6	9.8
	−1.4	4.2	5.0	3.3	1.8	10.2	5.3	10.3	4.0	10.3	9.9	29.5
	−1.4	4.2	5.0	3.3	1.8	10.2	5.3	10.3	4.0	10.3	9.9	29.5
	0.6	−0.7	−0.5	−2.8	−5.9	−2.7	3.5	−3.0	0.4	1.5	−0.0	0.3
	−0.9	3.5	4.6	0.5	−4.1	7.5	8.8	7.3	4.4	11.8	9.9	29.7
	—	4.2	5.0	3.3	1.8	10.2	5.3	10.3	4.0	10.3	—	—
Per share
	−₹0.27	₹0.79	₹0.95	₹0.62	₹0.34	₹1.92	₹0.99	₹1.93	₹0.75	₹1.94	₹1.87	₹5.69
	−₹0.27	₹0.79	₹0.95	₹0.62	₹0.34	₹1.92	₹0.99	₹1.93	₹0.75	₹1.94	₹1.87	₹5.69
Other comprehensive income — detail
	0.6	−0.7	−0.5	−2.8	−5.9	−2.7	—	—	—	—	—	—
	0.2	−0.4	−0.1	−0.1	—	—	−0.0	−0.0	−0.0	—	−0.0	—
	0.0	0.3	−0.0	−0.0	—	—	—	—	—	—	—	—
	—	—	—	—	—	—	−0.0	−0.0	−0.0	—	−0.0	—
	0.4	—	−0.4	−2.8	−5.9	−2.7	3.5	−3.0	0.4	1.6	—	—
	0.0	0.0	0.0	0.0	−0.0	−0.0	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	0.0	0.0	0.1	—	—
	0.0	4.2	5.0	0.0	—	—	—	—	4.0	—	—	—
Per share — as-filed variants
	−₹0.27	₹0.79	₹0.95	₹0.62	₹0.34	₹1.92	₹0.99	₹1.93	₹0.75	₹1.94	₹1.87	₹5.69
	−₹0.27	₹0.79	₹0.95	₹0.62	₹0.34	₹1.92	₹0.99	₹1.93	₹0.75	₹1.94	₹1.87	₹5.69
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	71.5	79.7	72.7	69.1	62.1	74.8	64.4	66.6	57.1	72.5	45.1	66.0
	64.9%	65.9%	67.4%	67.5%	67.9%	66.4%	67.3%	67.1%	67.4%	68.6%	73.0%	77.7%
Adjusted (ex-exceptional items) — derived
	−1.3	5.5	8.9	5.6	3.0	15.6	8.0	14.9	6.3	17.0	13.6	39.2
	0.0	0.2	−1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−1.4	4.0	5.9	3.3	1.8	10.2	5.3	10.3	4.0	10.3	9.9	29.5
	−₹0.27	₹0.76	₹1.12	₹0.62	₹0.34	₹1.92	₹0.99	₹1.93	₹0.75	₹1.94	₹1.87	₹5.69

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TARSONS₹303.95

Tarsons Products Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersFISCHER LAXMIDENTL FABTECH GKBMcap ₹1,617 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY22 31/03/2022	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	84.9	61.8	105.7	84.8	99.2	95.7	112.7	91.4	102.3	107.9	120.9	110.2
Other Income	2.6	3.2	3.4	2.9	8.4	0.8	3.8	3.3	5.8	8.4	6.6	6.0
Total Income	87.5	65.0	109.1	87.7	107.7	96.5	116.5	94.7	108.1	116.3	127.5	116.2
Expenses
+ Cost of Materials Consumed	20.0	15.3	16.3	20.3	18.3	19.6	21.9	15.8	17.3	17.9	21.9	22.2
+ Purchases of Stock-in-Trade	2.9	2.0	8.7	15.1	13.0	11.2	11.8	10.6	10.4	14.3	14.5	12.6
+ Changes in Inventories	-3.9	-0.7	8.2	-7.7	1.4	0.5	4.2	2.9	5.5	3.0	4.8	3.9
+ Employee Benefit Expense	8.6	9.8	15.6	16.1	16.1	16.4	16.8	17.9	17.8	19.5	20.4	21.2
+ Finance Costs	0.5	2.5	4.3	4.3	4.8	5.0	5.2	5.1	5.2	6.0	6.3	6.3
+ Depreciation & Amortisation	7.2	10.1	12.3	11.0	14.0	17.4	20.0	19.9	22.5	25.0	29.1	27.0
+ Other Expenses	13.0	12.5	26.7	22.3	25.2	18.4	21.0	19.5	23.8	21.7	25.1	24.3
Total Expenses	48.3	51.5	92.1	81.4	92.8	88.5	100.9	91.7	102.5	107.5	122.0	117.5
EBITDA	44.3	22.9	30.2	18.8	25.3	29.6	37.0	24.7	27.4	31.5	34.3	26.0
EBIT	37.1	12.8	17.9	7.7	11.3	12.2	17.0	4.8	5.0	6.5	5.2	-1.0
Profit
PBT before Exceptional Items	39.2	13.6	17.0	6.3	14.9	8.0	15.6	3.0	5.6	8.9	5.5	-1.3
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.3	0.2	0.0
Pretax Income	39.2	13.6	17.0	6.3	14.9	8.0	15.6	3.0	5.6	7.5	5.8	-1.3
+ Current Tax	9.1	3.3	8.2	2.5	3.6	2.5	6.3	1.3	2.3	2.5	0.0	0.2
+ Deferred Tax	0.6	0.4	-1.4	-0.2	1.0	0.3	-0.9	-0.1	-0.0	-0.0	1.6	-0.1
Tax Expense	9.8	3.6	6.7	2.3	4.6	2.8	5.4	1.2	2.3	2.5	1.6	0.1
Net Income	29.5	9.9	10.3	4.0	10.3	5.3	10.2	1.8	3.3	5.0	4.2	-1.4
+ Net Income — Continuing Ops	29.5	9.9	10.3	4.0	10.3	5.3	10.2	1.8	3.3	5.0	4.2	-1.4
+ Other Comprehensive Income	0.3	-0.0	1.5	0.4	-3.0	3.5	-2.7	-5.9	-2.8	-0.5	-0.7	0.6
Total Comprehensive Income	29.7	9.9	11.8	4.4	7.3	8.8	7.5	-4.1	0.5	4.6	3.5	-0.9
Net Income to Common	—	—	10.3	4.0	10.3	5.3	10.2	1.8	3.3	5.0	4.2	—
Per Share
Basic EPS	5.69	1.87	1.94	0.75	1.93	0.99	1.92	0.34	0.62	0.95	0.79	-0.27
Diluted EPS	5.69	1.87	1.94	0.75	1.93	0.99	1.92	0.34	0.62	0.95	0.79	-0.27
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-2.7	-5.9	-2.8	-0.5	-0.7	0.6
+ Items NOT to be Reclassified to P&L	—	-0.0	—	-0.0	-0.0	-0.0	—	—	-0.1	-0.1	-0.4	0.2
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	—	—	-0.0	-0.0	0.3	0.0
+ Tax on Items NOT to be Reclassified — alt tag	—	-0.0	—	-0.0	-0.0	-0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	—	—	1.6	0.4	-3.0	3.5	-2.7	-5.9	-2.8	-0.4	—	0.4
+ Tax on Items to be Reclassified	—	—	—	—	—	—	-0.0	-0.0	0.0	0.0	0.0	0.0
+ Tax on Items to be Reclassified — alt tag	—	—	0.1	0.0	0.0	0.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	—	—	—	4.0	—	—	—	—	0.0	5.0	4.2	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	5.69	1.87	1.94	0.75	1.93	0.99	1.92	0.34	0.62	0.95	0.79	-0.27
Diluted EPS — Continuing Operations	5.69	1.87	1.94	0.75	1.93	0.99	1.92	0.34	0.62	0.95	0.79	-0.27
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	66.0	45.1	72.5	57.1	66.6	64.4	74.8	62.1	69.1	72.7	79.7	71.5
Gross Margin %	77.65	73.04	68.58	67.36	67.13	67.34	66.37	67.93	67.52	67.43	65.95	64.89
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	39.2	13.6	17.0	6.3	14.9	8.0	15.6	3.0	5.6	8.9	5.5	-1.3
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.3	0.2	0.0
Net Income Adj (tax-effected)	29.5	9.9	10.3	4.0	10.3	5.3	10.2	1.8	3.3	5.9	4.0	-1.4
EPS Adj	5.69	1.87	1.94	0.75	1.93	0.99	1.92	0.34	0.62	1.12	0.76	-0.27
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	10.6	10.6	10.6	10.6	10.6	10.6	10.6	10.6	10.6	10.6	10.6	10.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Tarsons Products quarterly results

Tarsons Products (NSE: TARSONS) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net loss was ₹1.4 crore, against a profit of ₹1.8 crore in Q1 FY26 and against a profit of ₹4.2 crore in Q4 FY26. Revenue from operations was ₹110 crore, up 20.7% year on year and down 8.8% from the previous quarter.

Q2 FY26 results (a year earlier): 12 November 2025
Q1 FY27 results (the latest): 10 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net loss: −₹1.4 Crprofit ₹1.8 Cr in Q1 FY26profit ₹4.2 Cr in Q4 FY26
Q1 FY27 revenue: ₹110 Cr+20.7% vs Q1 FY26−8.8% vs Q4 FY26
Q1 FY27 operating margin: −0.9%−6.2 pts vs Q1 FY26−5.2 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹3.3 CrRevenue ₹102 Cr
Q1 FY27 EPS (basic): −₹0.27

Questions

When will Tarsons Products announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 12 November 2025.

What will Tarsons Products' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹3.3 crore and revenue from operations ₹102 crore. The latest quarter, Q1 FY27, had a net loss of ₹1.4 crore and revenue of ₹110 crore.

What were Tarsons Products' Q1 FY27 results?

Consolidated net loss was ₹1.4 crore, against a profit of ₹1.8 crore in Q1 FY26 and against a profit of ₹4.2 crore in Q4 FY26. Revenue from operations was ₹110 crore, up 20.7% year on year and down 8.8% from the previous quarter.

How has Tarsons Products' profit changed over the last four quarters?

Net profit by quarter: a profit of ₹3.3 crore in Q2 FY26, a profit of ₹5 crore in Q3 FY26, a profit of ₹4.2 crore in Q4 FY26 and a loss of ₹1.4 crore in Q1 FY27. That is a combined profit of ₹11.1 crore over the four quarters, down 59.7% from ₹27.5 crore in the four quarters before. Revenue from operations: ₹102 crore, ₹108 crore, ₹121 crore and ₹110 crore.

What was Tarsons Products' net profit in FY26?

Consolidated net profit was ₹14.3 crore in FY26 (April 2025–March 2026), down 51.9% from ₹29.8 crore in FY25. It was ₹42.6 crore in FY24.

What was Tarsons Products' revenue in FY26?

Revenue from operations was ₹423 crore in FY26 (April 2025–March 2026), up 7.7% from ₹392 crore in FY25. It was ₹296 crore in FY24.

Where do these Tarsons Products figures come from?

From Tarsons Products' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.